bf/NASDAQ:JSPR_icon.jpeg

NASDAQ:JSPR

Jasper Therapeutics

  • Stock

USD

Last Close

21.26

26/07 20:00

Market Cap

299.75M

Beta: 1.99

Volume Today

193.96K

Avg: 1.11M

PE Ratio

−22.01

PFCF: −2.88

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-9.99M
-
-9.75M
2.33%
-8.41M
13.74%
-3.41M
59.45%
-9.06M
165.45%
-2.21M
75.63%
-10.40M
371.41%
-11.86M
14.02%
-13.21M
11.36%
-14.26M
7.94%
-16.08M
12.76%
-17.54M
9.10%
-16.58M
5.49%
-13.73M
17.21%
depreciation and amortization
22K
-
29K
31.82%
132K
355.17%
194K
46.97%
216K
11.34%
218K
0.93%
268K
22.94%
273K
1.87%
274K
0.37%
275K
0.36%
276K
0.36%
283K
2.54%
288K
1.77%
deferred income tax
3.50M
-
-450K
-
-50K
88.89%
-831K
-
stock based compensation
437K
-
327K
25.17%
295K
9.79%
195K
33.90%
231K
18.46%
778K
236.80%
1.06M
36.89%
644K
39.53%
1.60M
149.07%
1.27M
21.01%
1.39M
9.79%
1.40M
0.29%
1.16M
16.99%
1.17M
0.95%
change in working capital
125K
-
-387K
409.60%
2.21M
671.32%
2.68M
21.39%
-2.89M
207.56%
-2.41M
16.42%
1.14M
147.24%
1.79M
57.46%
-1.17M
165.24%
946K
180.79%
1.46M
54.33%
4.12M
182.19%
-1.42M
134.54%
-3.60M
153.06%
accounts receivables
-663K
-
663K
200%
-663K
-
inventory
663K
-
283K
57.32%
-283K
-
accounts payables
-1.24M
-
83K
106.67%
1.55M
1,763.86%
-410K
126.50%
1.72M
519.02%
-2.45M
242.78%
1.48M
160.17%
175K
88.14%
-1.35M
870.86%
2.08M
254.04%
-2.27M
209.00%
1.68M
173.95%
893K
46.69%
-1.76M
296.86%
other working capital
1.37M
-
-470K
134.33%
664K
241.28%
3.09M
365.96%
-4.61M
248.84%
40K
100.87%
-336K
940%
1.62M
582.14%
178K
89.01%
-2.08M
1,267.42%
3.73M
279.26%
2.44M
34.36%
-1.37M
156.03%
-1.84M
34.53%
other non cash items
4.03M
-
96K
97.62%
88K
8.33%
-6.26M
7,210.23%
-3.02M
51.81%
-10.59M
251.14%
-1.38M
87.01%
-487K
64.58%
-141K
71.05%
1.44M
1,119.86%
-318K
122.11%
-228K
28.30%
915K
501.32%
3.64M
297.70%
net cash provided by operating activities
-5.39M
-
-6.20M
14.87%
-5.79M
6.52%
-7.11M
22.74%
-14.58M
105.18%
-14.21M
2.54%
-9.36M
34.17%
-9.64M
3.07%
-12.65M
31.14%
-10.34M
18.27%
-13.27M
28.42%
-11.98M
9.73%
-16.48M
37.54%
-15.74M
4.51%
investments in property plant and equipment
-960K
-
-287K
70.10%
-470K
63.76%
-711K
51.28%
-29K
95.92%
-243K
737.93%
-222K
8.64%
-82K
63.06%
-26K
68.29%
-11K
57.69%
-230K
-
-25K
89.13%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-960K
-
-287K
70.10%
-470K
63.76%
-711K
51.28%
-29K
95.92%
-243K
737.93%
-222K
8.64%
-82K
63.06%
-26K
68.29%
-11K
57.69%
-230K
-
-25K
89.13%
debt repayment
common stock issued
10.75M
-
1K
-
27K
2,600%
101.48M
375,748.15%
356K
99.65%
36K
89.89%
28K
22.22%
47.35M
169,003.57%
common stock repurchased
28K
-
-661
-
64.66K
-
dividends paid
other financing activites
10.80M
-
10.75M
0.47%
-600K
105.58%
91.73M
15,387.67%
-11.66M
112.71%
13K
100.11%
13K
0%
-27K
-
32K
218.52%
-660.34K
2,163.56%
-363.66K
-
154K
142.35%
net cash used provided by financing activities
10.80M
-
10.75M
0.47%
-600K
105.58%
91.73M
15,387.67%
-909K
100.99%
13K
101.43%
13K
0%
1K
92.31%
28K
2,700%
101.51M
362,439.29%
-305K
100.30%
36K
111.80%
-271K
852.78%
47.35M
17,571.96%
effect of forex changes on cash
net change in cash
5.41M
-
3.60M
33.51%
-6.68M
285.65%
84.15M
1,360.08%
-16.20M
119.26%
-14.23M
12.19%
-9.59M
32.63%
-9.86M
2.90%
-12.70M
28.75%
91.15M
817.72%
-13.59M
114.91%
-11.95M
12.09%
-16.98M
42.15%
31.59M
286.03%
cash at beginning of period
14.77M
-
20.18M
36.62%
23.78M
17.82%
17.10M
28.08%
101.25M
492.04%
85.05M
16.00%
70.82M
16.73%
61.23M
13.54%
51.37M
16.11%
38.67M
24.72%
129.82M
235.73%
116.23M
10.47%
103.87M
10.64%
86.89M
16.35%
cash at end of period
20.18M
-
23.78M
17.82%
17.10M
28.08%
101.25M
492.04%
85.05M
16.00%
70.82M
16.73%
61.23M
13.54%
51.37M
16.11%
38.67M
24.72%
129.82M
235.73%
116.23M
10.47%
104.28M
10.28%
86.89M
16.68%
118.47M
36.36%
operating cash flow
-5.39M
-
-6.20M
14.87%
-5.79M
6.52%
-7.11M
22.74%
-14.58M
105.18%
-14.21M
2.54%
-9.36M
34.17%
-9.64M
3.07%
-12.65M
31.14%
-10.34M
18.27%
-13.27M
28.42%
-11.98M
9.73%
-16.48M
37.54%
-15.74M
4.51%
capital expenditure
-960K
-
-287K
70.10%
-470K
63.76%
-711K
51.28%
-29K
95.92%
-243K
737.93%
-222K
8.64%
-82K
63.06%
-26K
68.29%
-11K
57.69%
-230K
-
-25K
89.13%
free cash flow
-5.39M
-
-7.16M
32.67%
-6.08M
15.05%
-7.58M
24.68%
-15.29M
101.83%
-14.24M
6.88%
-9.60M
32.60%
-9.87M
2.77%
-12.73M
29.02%
-10.36M
18.60%
-13.28M
28.20%
-11.98M
9.80%
-16.71M
39.46%
-15.76M
5.67%

All numbers in USD (except ratios and percentages)